Not Signed In - Gen-Probe Receives FDA Clearance To Run Standalone APTIMA(R) Tests For Chlamydia And Gonorrhea On The TIGRIS(R) System
Thu, 19 Oct 2006 07:00 AM EST
... Gen-Probe (Nasdaq: GPRO) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing clearance to run the Company's standalone APTIMA(R) assays for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) on the high-throughput, fully automated TIGRIS(R) system. [click link for full article] ...
Related Topics
- Chlamydia
- Gonorrhea
- Creatinine Clearance
- Chlamydia Infections
- Immune System
- American pennyroyal
- Digestive System
- Endocrine System
- Health System
- Creatinine
- Mammography
- Gram Stain
- Gonorrhea and Drug Resistance
- Tacrolimus ointment
- Laboratory Tests
- Chlamydia pneumoniae Infection
- Azithromycin
- Senna Laxatives
- Brahmi
- Carcinogens
email this page
print this page
bookmark this page
feedback on this page
